UTI Clinical Practice Guidelines – Philippines
First-Line Antibiotic Therapy for Uncomplicated Cystitis in Adults
For otherwise healthy, non-pregnant Filipino adults with uncomplicated cystitis, prescribe nitrofurantoin 100 mg orally twice daily for 5 days as the preferred first-line agent. 1, 2
Primary Treatment Options
Nitrofurantoin 100 mg PO BID × 5 days achieves approximately 93% clinical cure and 88% microbiological eradication, with worldwide resistance rates below 1% and minimal disruption of intestinal flora. 1, 2
Fosfomycin trometamol 3 g as a single oral dose provides 91% clinical cure with therapeutic urinary concentrations maintained for 24–48 hours; this single-dose regimen maximizes adherence. 1, 2
Trimethoprim-sulfamethoxazole (TMP-SMX) 160/800 mg PO BID × 3 days should be used only when local E. coli resistance is <20% and the patient has not received TMP-SMX in the preceding 3 months; verify local antibiogram data before prescribing. 1, 2
Contraindications to First-Line Agents
Avoid nitrofurantoin when estimated glomerular filtration rate (eGFR) is <30 mL/min/1.73 m² or for suspected pyelonephritis, because adequate urinary concentrations cannot be achieved. 1
Do not use fosfomycin for suspected pyelonephritis or upper urinary tract infections due to insufficient tissue penetration. 1
Do not prescribe TMP-SMX empirically unless local E. coli resistance is confirmed <20%; treatment failure rates rise sharply above this threshold. 1
Reserve (Second-Line) Agents – Use Only After Culture-Proven Resistance
Fluoroquinolones (ciprofloxacin 250–500 mg PO BID or levofloxacin 250–750 mg PO daily × 3 days) should be reserved exclusively for culture-proven resistant pathogens or documented failure of first-line therapy, because serious adverse effects (tendon rupture, peripheral neuropathy, CNS toxicity) outweigh benefits in uncomplicated UTI. 1
Beta-lactams (amoxicillin-clavulanate, cefdinir, cefpodoxime × 3–7 days) achieve only 89% clinical cure and 82% microbiological eradication—significantly inferior to first-line agents—and should be used only when all first-line options are contraindicated. 1, 2
Amoxicillin or ampicillin alone should never be used because worldwide E. coli resistance exceeds 55–67%. 1
Diagnostic Recommendations
When Urine Culture Is NOT Required
- Routine urine culture is unnecessary for otherwise healthy women presenting with typical lower urinary tract symptoms (dysuria, frequency, urgency) in the absence of vaginal discharge. 1, 2
When Urine Culture IS Mandatory
Obtain urine culture and susceptibility testing when any of the following occur: 1, 2
- Persistent symptoms after completing the prescribed regimen
- Recurrence of symptoms within 2–4 weeks
- Fever >38°C, flank pain, or costovertebral angle tenderness (suggesting pyelonephritis)
- Atypical presentation or presence of vaginal discharge
- Pregnancy with urinary symptoms
- History of recurrent infections or prior resistant organisms
Management of Treatment Failure
If symptoms persist after 2–3 days or recur within 2 weeks, obtain urine culture and susceptibility testing immediately, then switch to a different antibiotic class for a 7-day course (not the original short regimen). 1, 2
Assume the original pathogen is resistant to the initially used agent when retreating. 1
Reserve fluoroquinolones only for culture-proven resistance to all first-line agents. 1
Acute Pyelonephritis (Upper Urinary Tract Infection)
For suspected pyelonephritis (fever >38°C, flank pain, CVA tenderness), do not use nitrofurantoin or fosfomycin; instead prescribe:
Ciprofloxacin 500–750 mg PO BID × 7 days or levofloxacin 750 mg PO daily × 5–7 days if local fluoroquinolone resistance is <10%. 1, 2
Ceftriaxone 1–2 g IV once daily for patients requiring parenteral therapy or when fluoroquinolone resistance exceeds 10%. 1, 2
If fever persists beyond 72 hours, perform renal ultrasound or CT imaging to exclude obstruction or abscess. 1
Pregnancy-Specific Recommendations
First-Line Options for Pregnant Women
Fosfomycin 3 g single oral dose is safe throughout all trimesters and preferred for both asymptomatic bacteriuria and symptomatic cystitis. 1
Nitrofurantoin 100 mg PO BID × 5–7 days is safe in pregnancy but should be avoided after 36 weeks gestation due to theoretical risk of neonatal hemolytic anemia. 1
Amoxicillin 500 mg PO TID × 3–7 days is safe in all trimesters when the organism is susceptible. 1
Agents to Avoid in Pregnancy
Avoid TMP-SMX in the first trimester (neural tube defect risk) and third trimester (neonatal hyperbilirubinemia/kernicterus risk); may consider in second trimester only if local resistance is <20% and other agents are unsuitable. 1
Mandatory urine culture before initiating therapy in any pregnant woman with urinary symptoms. 1
Post-treatment urine culture 7 days after completing therapy to confirm microbiological cure. 1
Pediatric UTI Management
Diagnostic Criteria
Pyuria (≥10 WBC/HPF or positive leukocyte esterase) plus acute urinary symptoms (dysuria, frequency, urgency, fever >38.3°C, or gross hematuria) must both be present before starting antimicrobial therapy. 3
The absence of pyuria can help rule out infection in most pediatric populations, but the positive predictive value of pyuria alone is exceedingly low. 3
Treatment Principles
Evidence-based diagnosis should be primarily based on clinical symptoms, integrated with urinalysis findings; do not rely solely on urinalysis alone. 3
Urine cultures are reasonable for complicated cases, recurrent UTIs, or suspected pyelonephritis to guide targeted therapy; routine cultures are not necessary for simple uncomplicated cystitis in healthy children. 3
Critical Pitfalls to Avoid
Do not treat asymptomatic bacteriuria in non-pregnant, non-catheterized patients; this promotes resistance without clinical benefit and paradoxically increases recurrent UTI episodes. 1, 2
Do not use empiric fluoroquinolones as first-line therapy for uncomplicated cystitis; reserve them for complicated infections or culture-proven resistance. 1, 2
Do not prescribe nitrofurantoin for suspected pyelonephritis or when eGFR <30 mL/min/1.73 m². 1
Do not use oral fosfomycin for suspected upper urinary tract infection or pyelonephritis. 1
Verify local TMP-SMX resistance patterns before empirical use; if data are unavailable, default to nitrofurantoin or fosfomycin. 1
Recurrent UTI Prevention Strategies
For Postmenopausal Women
- Vaginal estrogen therapy (with or without lactobacillus-containing probiotics) reduces future UTI risk. 2
For Premenopausal Women
Post-coital prophylaxis: Low-dose antibiotic within 2 hours of sexual activity for 6–12 months for women with post-coital infections. 2
Daily prophylaxis: Nitrofurantoin for 6–12 months for patients with ≥3 UTIs per year (or ≥2 in 6 months) unrelated to sexual activity. 2
Non-Antibiotic Alternatives
Methenamine hippurate (alone or with lactobacillus probiotics) is an acceptable non-antibiotic prophylactic option. 2
Cranberry products in tolerable formulations may be used as adjunctive preventive measures. 2
Maintain adequate hydration, void shortly after sexual activity, and avoid spermicide-containing contraceptives. 2